We are live on ! Find out more
DERM icon

Journey Medical
DERM

36 hedge funds and large institutions have $8.08M invested in Journey Medical in 2023 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

375% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 4

267% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 3

71% more funds holding

Funds holding: 21 → 36 (+15)

38% more capital invested

Capital invested by funds: $5.85M → $8.08M (+$2.23M)

6.25% less ownership

Funds ownership: 17.11% → 10.86% (-6.2%)

Holders
36
Holders Change
+15
Holders Change %
+71.43%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
11
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$1.07M
2
EI
EAM Investors
California
+$492K
3
Millennium Management
Millennium Management
New York
+$270K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$253K
5
BlackRock
BlackRock
New York
+$131K

Top Sellers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
-$1.58M
2
BRF
B. Riley Financial
California
-$1.18M
3
NCM
Nantahala Capital Management
Connecticut
-$955K
4
PCM
Perkins Capital Management
Minnesota
-$856K
5
Neuberger Berman Group
Neuberger Berman Group
New York
-$71.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
AFGAS
26
Allegiance Financial Group Advisory Services
Virginia
$57.6K – – –
Osaic Holdings
27
Osaic Holdings
Arizona
$31.4K +$24.3K +5,455 New
TAM
28
Tucker Asset Management
Colorado
$15K +$11.6K +2,600 New
Federated Hermes
29
Federated Hermes
Pennsylvania
$4.8K +$3.71K +833 New
Morgan Stanley
30
Morgan Stanley
New York
$2.3K +$1.78K +400 New
Lazard Asset Management
31
Lazard Asset Management
New York
$2K +$1.56K +351 New
Bank of America
32
Bank of America
North Carolina
$991 +$766 +172 New
Fidelity Investments
33
Fidelity Investments
Massachusetts
$734 +$570 +128 New
JP Morgan Chase
34
JP Morgan Chase
New York
$645 +$468 +105 +1,500%
Wells Fargo
35
Wells Fargo
California
$346 +$18 +4 +7%
TCM
36
Tang Capital Management
California
– -$1.58M -576,100 Closed
BRF
37
B. Riley Financial
California
– -$1.18M -429,595 Closed
NCM
38
Nantahala Capital Management
Connecticut
– -$955K -348,663 Closed
TRCT
39
Tower Research Capital (TRC)
New York
– -$4.74K -1,730 Closed
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
– +$62 +14 +93%
1
2

DERM Hedge Fund Activity: Q4 2023 in Review

36 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Journey Medical (DERM) for Q4 2023, worth a combined $8.08M — up 38% from $5.85M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new DERM positions and 4 closed out — a net gain of 15 holders — while 11 added to existing stakes and 3 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $1.07M. The largest seller was Tang Capital Management, exiting entirely with an estimated $1.58M sold.

  • 36 institutional investors held Journey Medical (DERM) as of Q4 2023, up from 21 in Q3 2023.
  • Funds reported $8.08M of Journey Medical stock for Q4 2023, up 38% quarter-over-quarter.
  • 19 funds opened new Journey Medical positions in Q4 2023 and 4 closed out, a net change of +15 holders.
  • The largest Journey Medical buyer in Q4 2023 was Renaissance Technologies, an estimated $1.07M added.
  • The largest Journey Medical seller in Q4 2023 was Tang Capital Management, an estimated $1.58M sold.

Based on aggregated 13F filings for Q4 2023.